Abstract
There is a high prevalence of pain, depression, and cognitive dysfunction in patients with Multiple Sclerosis (MS). These symptoms affect daily tasks resulting in a significant reduction in quality of life. Pain and cognitive changes have been studied across various animal models of MS. In these models the onset of pain and cognitive dysfunction occur early, and do not coincide with the pattern of motor deficits. This is likely underpinned by a number of different mechanisms including changes in glutamate transmission, glial cell activation, and increased levels of pro-inflammatory cytokines. Changes in pain and cognition have been described as belonging to a cluster of symptoms and have been linked through centrally driven processes. In particular, the overactive immune response can induce a state of “sickness-like behaviours” that can influence both pain and cognition. Investigating the mechanism of inflammatory sickness behaviors in MS could lead to a better understanding of the links between pain and cognition. There are currently few effective treatments for pain and cognition dysfunction in MS. Studying the relationship between these symptoms will allow better management of both symptoms.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abhinav K et al (2012) Clinicopathological review of patients with and without multiple sclerosis treated by partial sensory rhizotomy for medically refractory trigeminal neuralgia: a 12-year retrospective study. Clin Neurol Neurosurg 114:361–365
Aicher SA et al (2004) Hyperalgesia in an animal model of multiple sclerosis. Pain 110:560–570
Al-Araji AH, Oger J (2005) Reappraisal of Lhermitte’s sign in multiple sclerosis. Mult Scler 11:398–402
Amato MP et al (2010) Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study. Mult Scler 16:1474–1482
Archibald CJ et al (1994) Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients. Pain 58:89–93
Beggs S et al (2012) P2X4R + microglia drive neuropathic pain. Nat Neurosci 15:1068–1073
Beiske AG et al (2009) Pain in Parkinson’s disease: prevalence and characteristics. Pain 141:173–177
Berard JL et al (2010) Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice. Glia 58:434–445
Bergendal G et al (2007) Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study. Eur Neurol 57:193–202
Blank T, Prinz M (2013) Microglia as modulators of cognition and neuropsychiatric disorders. Glia 61:62–70
Butler MA et al (2009) How the conflict between American psychiatry and neurology delayed the appreciation of cognitive dysfunction in multiple sclerosis. Neuropsychol Rev 19:399–410
Calabrese M et al (2009) Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 66:1144–1150
Chwastiak L et al (2002) Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry 159:1862–1868
Compston A, Coles A (2002) Multiple sclerosis. Lancet 359:1221–1231
Cruccu G et al (2009) Trigeminal neuralgia and pain related to multiple sclerosis. Pain 143:186–191
D’Intino G et al (2005) Cognitive deficit associated with cholinergic and nerve growth factor down-regulation in experimental allergic encephalomyelitis in rats. Proc Natl Acad Sci USA 102:3070–3075
Dantzer R (2001) Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 933:222–234
David S, Kroner A (2011) Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci 12:388–399
DeLuca J et al (1998) Acquisition and storage deficits in multiple sclerosis. J Clin Exp Neuropsychol 20:376–390
Demaree HA et al (2000) Learning impairment is associated with recall ability in multiple sclerosis. J Clin Exp Neuropsychol 22:865–873
Denney DR et al (2008) A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters. J Neurol Sci 267:129–136
Dutra RC et al (2013a) The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: evidence for the involvement of astrocytes. Neurobiol Dis 54:82–93
Dutra RC, Moreira EL, Alberti TB, Marcon R, Prediger RD, Calixto JB (2013b) Spatial reference memory deficits precede motor dysfunction in an experimental autoimmune encephalomyelitis model: the role of kallikrein-kinin system. Brain Behav Immun 33:90–101
Feinstein A (2011) Multiple sclerosis and depression. Mult Scler 17:1276–1281
Feinstein A et al (2004) Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 62:586–590
Fletcher JM et al (2010) T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 162:1–11
Foley PL et al (2013) Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta-analysis. Pain 154:632–642
Friese MA, Fugger L (2009) Pathogenic CD8(+) T cells in multiple sclerosis. Ann Neurol 66:132–141
Genova HM et al (2012) Processing speed versus working memory: contributions to an information-processing task in multiple sclerosis. Appl Neuropsychol Adult 19:132–140
Gold SM, O’Connor MF, Gill R, Kern KC, Shi Y, Henry RG et al (2014) Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling. Hum Brain Mapp 35:30–37
Grasso MG et al (2008) Pain in multiple sclerosis: a clinical and instrumental approach. Mult Scler 14:506–513
Guimaraes J, Sa MJ (2012) Cognitive dysfunction in multiple sclerosis. Front Neurol 3:74
Haji N et al (2012) TNF-alpha-mediated anxiety in a mouse model of multiple sclerosis. Exp Neurol 237:296–303
Hart RP et al (2000) Chronic pain and neuropsychological functioning. Neuropsychol Rev 10:131–149
Hauser SL and Oksenberg JR (2006) The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52:61–76
Heesen C et al (2006) Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J Neurol Neurosurg Psychiatry 77:34–39
Hirsh AT et al (2009) Prevalence and impact of pain in multiple sclerosis: physical and psychologic contributors. Arch Phys Med Rehabil 90:646–651
Huizinga R et al (2012) Phagocytosis of neuronal debris by microglia is associated with neuronal damage in multiple sclerosis. Glia 60:422–431
Ji RR, Berta T, Nedergaard M et al (2013) Glia and pain: is chronic pain a gliopathy? Pain 154(Suppl 1):S10–S28
Julian LJ (2011) Cognitive functioning in multiple sclerosis. Neurol Clin 29:507–525
Kelley KW et al (2003) Cytokine-induced sickness behavior. Brain Behav Immun 17(Suppl 1):S112–S118
Kim K et al (2011) Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J Cell Physiol 226:2484–2493
Krumbholz M et al (2012) B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nat Rev Neurol 8:613–623
Langdon DW (2011) Cognition in multiple sclerosis. Curr Opin Neurol 24:244–249
Lester K et al (2007) The association of illness severity, self-reported cognitive impairment, and perceived illness management with depression and anxiety in a multiple sclerosis clinic population. J Behav Med 30:177–186
Love S, Coakham HB (2001) Trigeminal neuralgia: pathology and pathogenesis. Brain 124:2347–2360
Love S et al (2001) Trigeminal neuralgia due to multiple sclerosis: ultrastructural findings in trigeminal rhizotomy specimens. Neuropathol Appl Neurobiol 27:238–244
Low LA (2013) The impact of pain upon cognition: what have rodent studies told us? Pain 154:2603–2605
Lynch JL et al (2008) Analysis of nociception, sex and peripheral nerve innervation in the TMEV animal model of multiple sclerosis. Pain 136:293–304
Maloni HW (2000) Pain in multiple sclerosis: an overview of its nature and management. J Neurosci Nurs 32(139–44):152
Maurelli M et al (1992) Neuropsychological assessment in MS: clinical, neurophysiological and neuroradiological relationships. Acta Neurol Scand 86:124–128
Mayo L et al (2012) The innate immune system in demyelinating disease. Immunol Rev 248:170–187
Moriarty O et al (2011) The effect of pain on cognitive function: a review of clinical and preclinical research. Prog Neurobiol 93:385–404
Motl RW et al (2010a) Symptoms and physical activity among adults with relapsing-remitting multiple sclerosis. J Nerv Ment Dis 198:213–219
Motl RW et al (2010b) Symptom cluster and quality of life in multiple sclerosis. J Pain Symptom Manage 39:1025–1032
Musgrave T et al (2011) The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE). Brain Behav Immun 25:1677–1688
Newland PK et al (2012) Symptom clusters in women with relapsing-remitting multiple sclerosis. J Neurosci Nurs 44:66–71
Nistico R et al (2013) Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis. PLoS One 8:e54666
O’Connor AB et al (2008) Pain associated with multiple sclerosis: systematic review and proposed classification. Pain 137:96–111
Olechowski CJ et al (2010) A diminished response to formalin stimulation reveals a role for the glutamate transporters in the altered pain sensitivity of mice with experimental autoimmune encephalomyelitis (EAE). Pain 149:565–572
Olechowski CJ et al (2013) Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE). Exp Neurol 241:113–121
Olechowski CJ et al (2009) Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Pain 141:156–164
Osterberg A et al (2005) Central pain in multiple sclerosis–prevalence and clinical characteristics. Eur J Pain 9:531–542
Pachner AR (2011) Experimental models of multiple sclerosis. Curr Opin Neurol 24:291–299
Papadopoulou A, Muller-Lenke N, Naegelin Y, Kalt G, Bendfeldt K, Kuster P et al (2013) Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis. Mult Scler 19:1290–1296
Patten SB et al (2005) Clinical correlates of CES-D depressive symptom ratings in an MS population. Gen Hosp Psychiatry 27:439–445
Pollak Y et al (2002) Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of ‘depression due to multiple sclerosis’. Brain Behav Immun 16:533–543
Pollak Y et al (2003) The EAE-associated behavioral syndrome: I. temporal correlation with inflammatory mediators. J Neuroimmunol 137:94–99
Pollak Y, Yirmiya R (2002) Cytokine-induced changes in mood and behaviour: implications for ‘depression due to a general medical condition’, immunotherapy and antidepressive treatment. Int J Neuropsychopharmacol 5:389–399
Rabins PV et al (1986) Structural brain correlates of emotional disorder in multiple sclerosis. Brain 109(Pt 4):585–597
Ransohoff RM (2012) Animal models of multiple sclerosis: the good, the bad and the bottom line. Nat Neurosci 15:1074–1077
Ransohoff RM, Perry VH (2009) Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 27:119–145
Rivers TM et al (1933) Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J Exp Med 58:39–53
Rogers JM, Panegyres PK (2007) Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations. J Clin Neurosci 14:919–927
Solaro C et al (2013) Pain and multiple sclerosis: pathophysiology and treatment. Curr Neurol Neurosci Rep 13:320
Sumowski JF, Leavitt VM, Cohen A, Paxton J, Chiaravalloti ND, DeLuca J (2013) Retrieval practice is a robust memory aid for memory-impaired patients with MS. Mult Scler 19:1943–1946
Thibault K et al (2011) Characterisation of sensory abnormalities observed in an animal model of multiple sclerosis: a behavioural and pharmacological study. Eur J Pain 15(231):e1–e16
Thornton AE et al (2002) Memory in multiple sclerosis: contextual encoding deficits. J Int Neuropsychol Soc 8:395–409
Truini A et al (2013) A mechanism-based classification of pain in multiple sclerosis. J Neurol 260:351–367
Wood B et al (2013) Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis. Mult Scler 19:217–224
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Benson, C., Kerr, B.J. (2014). Pain and Cognition in Multiple Sclerosis. In: Taylor, B., Finn, D. (eds) Behavioral Neurobiology of Chronic Pain. Current Topics in Behavioral Neurosciences, vol 20. Springer, Berlin, Heidelberg. https://doi.org/10.1007/7854_2014_309
Download citation
DOI: https://doi.org/10.1007/7854_2014_309
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45093-2
Online ISBN: 978-3-662-45094-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)